Wave Life Sciences, Inc. (WVE)
4.86
+0.16
(+3.40%)
USD |
NASDAQ |
Sep 04, 16:00
4.855
0.00 (0.00%)
After-Hours: 20:00
Wave Life Sciences Debt to Equity Ratio : 0.0961 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.0961 |
| March 31, 2026 | 0.0307 |
| December 31, 2025 | 0.0338 |
| September 30, 2025 | 0.1493 |
| June 30, 2025 | 0.1476 |
| March 31, 2025 | 0.1313 |
| December 31, 2024 | 0.1169 |
| September 30, 2024 | 0.1817 |
| June 30, 2024 | 6.567 |
| March 31, 2024 | 0.918 |
| December 31, 2023 | 0.6761 |
| September 30, 2023 | -1.032 |
| June 30, 2023 | -0.8019 |
| March 31, 2023 | -1.364 |
| December 31, 2022 | -1.011 |
| September 30, 2022 | 11.50 |
| June 30, 2022 | 1.018 |
| March 31, 2022 | 3.674 |
| December 31, 2021 | 0.741 |
| September 30, 2021 | 0.7035 |
| June 30, 2021 | 0.9259 |
| March 31, 2021 | 0.4683 |
| Date | Value |
|---|---|
| December 31, 2020 | 0.3233 |
| September 30, 2020 | 0.2598 |
| June 30, 2020 | 9.154 |
| March 31, 2020 | 1.106 |
| December 31, 2019 | 0.4545 |
| September 30, 2019 | 0.2715 |
| June 30, 2019 | 0.2023 |
| March 31, 2019 | 0.1695 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.0001 |
| September 30, 2017 | 0.0161 |
| June 30, 2017 | 0.0131 |
| March 31, 2017 | 0.01 |
| December 31, 2016 | 0.0005 |
| September 30, 2016 | 0.0006 |
| June 30, 2016 | 0.0006 |
| March 31, 2016 | 0.0008 |
| December 31, 2015 | 0.0009 |
| September 30, 2015 | -0.05 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Filana Therapeutics, Inc. | 0.00 |
| CorMedix, Inc. | 0.315 |
| Eloxx Pharmaceuticals, Inc. | 0.00 |
| Cannabis Global, Inc. | -- |
| Breakthrough Chemistry, Inc. | 0.2335 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 558.32M |
| Total Liabilities (Quarterly) | 104.80M |
| Shareholders Equity (Quarterly) | 453.52M |
| Current Ratio | 9.987 |
| Net Debt Paydown Yield | -0.36% |